References
- Krueger DA, Care MM, Holland K, et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 2010;363:1801-11
- Krueger DA, Franz DN. Current management of tuberous sclerosis complex. Paediatr Drugs 2008;10:299-313
- Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediat Neurol 2013;49:243-54
- Lennert B, Farrelly E, Sacco P, et al. Resource utilization in children with tuberous sclerosis complex and associated seizures: a retrospective chart review study. J Child Neurol 2013;28:461-9
- Hallett L, Foster T, Liu Z, et al. Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review. Curr Med Res Opin 2011;27:1571-83
- Rentz AM, Skalicky AM, Liu Z, et al. Tuberous sclerosis complex: a survey of health care resource use and health burden. Pediat Neurol 2015;52:435-41
- Rentz AM, Skalicky AM, Pashos CL, et al. Caring for children with tuberous sclerosis complex: what is the physical and mental health impact on caregivers? J Child Neurol 2015;30:1574-81
- Skalicky AM, Rentz AM, Liu Z, et al. The burden of subependymal giant cell astrocytomas associated with tuberous sclerosis complex: results of a patient and caregiver survey. J Child Neurol 2015;30:563-9
- Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics 1993;4:353-65
- Kimball AB, Yu AP, Signorovitch J, et al. The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis. J Am Acad Dermatol 2012;66:e67-76
- Coyle PK, Cohen BA, Leist T, et al. Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes. BMC Neurol 2014;14:49
- National Psoriasis Foundation (NPF). Portland, OR: NPF. Available from: https://www.psoriasis.org/ [Last accessed December 28, 2017]
- TS Alliance. Signs and symptoms of TSC. Silver Spring, MD: TS Alliance; 2017. Available from: http://www.tsalliance.org/about-tsc/signs-and-symptoms-of-tsc/; 2018 [Last accessed June 25, 2018]
- National Multiple Sclerosis Society. Available from: https://www.nationalmssociety.org/Symptoms-Diagnosis/MS-Symptoms [Last accessed June 25, 2018]
- National Institute of Neurological Disorders and Stroke (NINDS). Tuberous sclerosis fact sheet. NIH Publication No. 07-1846. Bethesda, MD: NINDS; May 10, 2017. Available from: https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Tuberous-Sclerosis-Fact-Sheet [Last accessed December 28, 2017]
- Kingswood JC, Crawford P, Johnson SR, et al. The economic burden of tuberous sclerosis complex in the UK: a retrospective cohort study in the Clinical Practice Research Datalink. J Med Econ 2016;19:1087-98
- Vekeman F, Magestro M, Karner P, et al. Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs. J Med Econ 2015;18:1060-70
- Shepherd C, Koepp M, Myland M, et al. Understanding the health economic burden of patients with tuberous sclerosis complex (TSC) with epilepsy: a retrospective cohort study in the UK Clinical Practice Research Datalink (CPRD). BMJ Open 2017;7:e015236
- Chevreul K, Brigham KB, Gandre C, et al. The economic burden and health-related quality of life associated with systemic sclerosis in France. Scand J Rheumatol 2015;44:238-46
- Krueger DA, Northrup H, International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediat Neurol 2013;49:255-65
- Van Lierde A, Menni F, Bedeschi MF, et al. Healthcare transition in patients with rare genetic disorders with and without developmental disability: neurofibromatosis 1 and Williams-Beuren syndrome. Am J Med Genet A 2013;161A:1666-74